Science Group at J.P. Morgan Healthcare 2019

The healthcare sector is a major focus for Science Group (AIM:SAG) a leading global, science-led advisory and product development organization. Science Group’s operating companies provide innovation services to medtech companies across the patient care continuum from the front end of innovation through go-to-market.

Oakland Innovation provides front-end-of innovation services to clients such as tech-scouting; product roadmapping and horizon scanning. In the last year we helped a number of clients develop and define value propositions especially around their digital offerings.

Sagentia is part of the Cambridge (UK) cluster of R&D development companies and provides ISO 13485 accredited product development services to a wide variety of clients, large and small. We have specific focuses in diagnostics, digital health, cell & gene therapy scale-up and development of medical devices more broadly.

TSG Consulting advises clients on regulatory issues related to taking medical devices to market. Over the last year, we have guided clients through successful 510(k) presubmission meetings for Class 2 medical devices, prepared 510(k) application packages for submission, and have advised a number of clients on optimal strategies for successful 510(k) submissions.

 

Capabilities

Case studies and insights from across the Group

Development of an advanced negative pressure wound therapy system

Read more

Updated cybersecurity guidance for medical devices

Read more

Scaling up a novel microfluidic process for drug production

Read more

Re-design of medical diagnostic consumable

Read more

Development of wearable drug delivery devices

Read more

Normalising connectivity - could unconnected devices become the exception?

Read more

Contact us

Complete our contact form for an informal chat with one of our technology consultants